Dov A. Goldstein M.D.

CIK: 0001120478

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (23.5%)

Position reduction

Option Exercises (M)6 (35.3%)

Derivative conversions

Awards (A)7 (41.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

GANX

Gain Therapeutics, Inc.

Director

BIOA

BioAge Labs, Inc.

Officer

COYA

Coya Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (17 total)

GANX
Gain Therapeutics, Inc.
Jul 15, 2026
Award(A)
Stock Option (right to buy)
Direct
25K shares-
BIOA
BioAge Labs, Inc.
Apr 23, 2026
Exercise(M)
Direct
3.5K shares at avg. $4.38$16K
BIOA
BioAge Labs, Inc.
Mar 1, 2026
Exercise(M)
Direct
3.5K shares at avg. $4.38$16K
BIOA
BioAge Labs, Inc.
Feb 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
110K shares-
BIOA
BioAge Labs, Inc.
Feb 1, 2026
Exercise(M)
Direct
3.5K shares at avg. $4.38$16K
BIOA
BioAge Labs, Inc.
Jan 16, 2026
Exercise(M)
Direct
3.5K shares at avg. $4.38$16K
BIOA
BioAge Labs, Inc.
Jan 13, 2026
Sale(S)
Direct
9K shares at avg. $18.43$165K
BIOA
BioAge Labs, Inc.
Jan 13, 2026
Sale(S)
Direct
4.4K shares at avg. $19.45$86K
BIOA
BioAge Labs, Inc.
Jan 13, 2026
Sale(S)
Direct
11.7K shares at avg. $20.54$240K
BIOA
BioAge Labs, Inc.
Jan 13, 2026
Sale(S)
Direct
1.9K shares at avg. $21.08$41K
BIOA
BioAge Labs, Inc.
Jan 13, 2026
Exercise(M)
Direct
27K shares at avg. $8.39$227K
COYA
Coya Therapeutics, Inc.
Jan 2, 2026
Award(A)
Stock Option (right to buy)
Direct
10K shares-
COYA
Coya Therapeutics, Inc.
Aug 18, 2025
Exercise(M)
Direct
17.6K shares at avg. $1.09$19K
GANX
Gain Therapeutics, Inc.
Jun 24, 2025
Award(A)
Stock Option (right to buy)
Direct
15K shares-
COYA
Coya Therapeutics, Inc.
Feb 25, 2025
Award(A)
Stock Option (right to buy)
Direct
5K shares-
BIOA
BioAge Labs, Inc.
Feb 18, 2025
Award(A)
Stock Option (Right to Buy)
Direct
170K shares-
COYA
Coya Therapeutics, Inc.
Jan 1, 2025
Award(A)
Stock Option (right to buy)
Direct
5K shares-

		Type	Shares	Price		Ownership
Jul 15, 2026	GANX Gain Therapeutics, Inc.	Award(A) Stock Option (right to buy)	25,000	-	-	Direct
Apr 23, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	3,542	$4.38	$15,514	Direct
Mar 1, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	3,542	$4.38	$15,514	Direct
Feb 17, 2026	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	110,000	-	-	Direct
Feb 1, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	3,541	$4.38	$15,510	Direct
Jan 16, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	3,542	$4.38	$15,514	Direct
Jan 13, 2026	BIOA BioAge Labs, Inc.	Sale(S)	8,974	$18.43	$165,371	Direct
Jan 13, 2026	BIOA BioAge Labs, Inc.	Sale(S)	4,440	$19.45	$86,370	Direct
Jan 13, 2026	BIOA BioAge Labs, Inc.	Sale(S)	11,663	$20.54	$239,549	Direct
Jan 13, 2026	BIOA BioAge Labs, Inc.	Sale(S)	1,923	$21.08	$40,538	Direct
Jan 13, 2026	BIOA BioAge Labs, Inc.	Exercise(M)	27,000	$8.39	$226,530	Direct
Jan 2, 2026	COYA Coya Therapeutics, Inc.	Award(A) Stock Option (right to buy)	10,000	-	-	Direct
Aug 18, 2025	COYA Coya Therapeutics, Inc.	Exercise(M)	17,557	$1.09	$19,137	Direct
Jun 24, 2025	GANX Gain Therapeutics, Inc.	Award(A) Stock Option (right to buy)	15,000	-	-	Direct
Feb 25, 2025	COYA Coya Therapeutics, Inc.	Award(A) Stock Option (right to buy)	5,000	-	-	Direct
Feb 18, 2025	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	170,000	-	-	Direct
Jan 1, 2025	COYA Coya Therapeutics, Inc.	Award(A) Stock Option (right to buy)	5,000	-	-	Direct

1-17 of 17 transactions

About GOLDSTEIN DOV A MD

GOLDSTEIN DOV A MD (SEC CIK 0001120478) files insider reports with the SEC as Director of Gain Therapeutics, Inc. (GANX), Chief Financial Officer of BioAge Labs, Inc. (BIOA) and Director of Coya Therapeutics, Inc. (COYA).

Signal8 holds 14 ownership filings by GOLDSTEIN DOV A MD (1 Form 3, 13 Form 4), filed between Sep 25, 2024 and Jul 17, 2026. Those filings report 17 transactions, from Jan 1, 2025 to Jul 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on GOLDSTEIN DOV A MD's filings is in BETHESDA, MD.

Recent filings by GOLDSTEIN DOV A MD

Jul 15, 2026: Grant or award of GANX derivative securities (Form 4, code A).
Apr 23, 2026: Option exercise of BIOA shares (Form 4, code M).
Mar 1, 2026: Option exercise of BIOA shares (Form 4, code M).
Feb 17, 2026: Grant or award of BIOA derivative securities (Form 4, code A).
Feb 1, 2026: Option exercise of BIOA shares (Form 4, code M).

Other insiders filing for Gain Therapeutics, Inc. (GANX)

How to read Form 4 transaction codes